Manufacturing Chemist Manufacturing Chemist
  • Home
  • Ingredients
  • Analysis
  • Manufacturing
  • Finance
  • Events
  • Directory
  • Regulatory
  • Drug Delivery
  • Research & Development
  • Sustainability

Kymab

www.kymab.com

Meditrina (B260)
Babraham Research Campus
Cambridge
CB22 3AT
United Kingdom

+44 1223 833301

Activities

Research & Development | Pharmaceutical

Related Companies

  • Lonza
  • Icrom SRL
  • Nanoform
  • Merck Life Science KGaA
  • Starlab
  • Edwards Vacuum
  • PCI Pharma Services
  • Curia
  • Solvias
  • Piramal Pharma Solutions
  • Butterworth Laboratories
  • Hermes Pharma GmbH
  • Ecolab Life Sciences
  • Marchesini Group
  • Vectorbuilder Inc
  • Rentschler Biopharma SE
  • Indena
  • Quotient Sciences
  • 3P innovation
  • Actylis – The Partner of Choice

Related Content

Kymab antibody could be used to treat leukemia
Kymab antibody could be used to treat leukemia
Kymab announce promising new antibody for autoimmune treatment
Kymab announce promising new antibody for autoimmune treatment
Kymab appoints Sonia Quaratino as Chief Medical Officer
Kymab appoints Sonia Quaratino as Chief Medical Officer
Kymab appoints Dr Arndt Schottelius as Executive VP, R&D
Kymab appoints Dr Arndt Schottelius as Executive VP, R&D
Kymab new therapeutic antibody for autoimmune diseases shows potential for improvement in post-transplant survival
Kymab new therapeutic antibody for autoimmune diseases shows potential for improvement in post-transplant survival
Kymab secures $100 million series C funding
Kymab secures $100 million series C funding
Human antibody discovery platform successfully demonstrates steps to developing HIV vaccine
Human antibody discovery platform successfully demonstrates steps to developing HIV vaccine
Kymab hires leaders in immuno-oncology, infectious disease and blood disorders
Kymab hires leaders in immuno-oncology, infectious disease and blood disorders
Heptares and Kymab enter into novel antibody therapeutics collaboration
Heptares and Kymab enter into novel antibody therapeutics collaboration
Kymab appoints Dr David Chiswell as Chief Executive
Kymab appoints Dr David Chiswell as Chief Executive
Kymab secures an additional US$50m in Series B funding
Kymab secures an additional US$50m in Series B funding
Christian Groendahl steps down as CEO of Kymab
Christian Groendahl steps down as CEO of Kymab
Kymab and the Wellcome Trust initiate Ebola project
Kymab and the Wellcome Trust initiate Ebola project
Kymab succeeds in revoking Regeneron’s European Patent
Kymab succeeds in revoking Regeneron’s European Patent
Kymab makes two management appointments
Kymab makes two management appointments
  • Advertise Subscribe
  • Terms & Conditions
  • Privacy Policy
  • Contact us at info@hpcimedia.com
Twitter LinkedIn RSS newsfeed
© HPCi Media Limited | Registered in England No. 6716035 | VAT GB 939828072 | a Claverley Group company